Community-based treatment for opioid dependent offenders: A pilot study

American Journal on Addictions

Volumn 22, Issue 5, 2013, Pages 500-502

  Brown, Randy ^a   Gassman, Michele ^a   Hetzel, Scott ^a   Berger, Lisa ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; METHADONE; OPIATE;

ADULT; ARTICLE; COMMUNITY BASED REHABILITATION; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG THERAPY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION RISK; MALE; MEDICAL SPECIALIST; OFFENDER; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; OPIOID DEPENDENT OFFENDER; PILOT STUDY; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL;

ADULT; CRIMINAL LAW; CRIMINALS; FEMALE; HUMANS; MALE; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PILOT PROJECTS; PRIMARY HEALTH CARE; SUBSTANCE ABUSE TREATMENT CENTERS;

EID: 84882595867     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2013.12049.x     Document Type: Article

References (10)

1. Bohnert AS, Fudalej S, Ilgen MA., Increasing poisoning mortality rates in the United States, 1999-2006. Public Health Rep. 2010; 125: 542-547.
2. SAMHSA. Drug Abuse Warning Network, 2006 National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: Substance Abuse & Mental Health Services Administration, Office of Applied Studies; 2008.
3. Magura S, Kang SY, Shapiro JL., Measuring cocaine use by hair analysis among criminally involved youth. J Drug Issues. 1995; 25: 683-701.
4. Nurco DN., A long-term program of research on drug use and crime. Subst Use Misuse. 1998; 33: 1817-1837.
5. Sobell LC, Sobell MB., Timeline follow-back: A technique for assessing self-reported alcohol consumption. In:, Litten RZ, Allen JP, eds. Measuring Alcohol Consumption: Psychosocial and Biochemical Methods, pp. 41-72. Totowa, NJ: Humana Press; 1992.
6. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the addiction severity index. J Subst Abuse Treat. 1992; 9: 199-213.
7. Metzger DS., The Risk Assessment Battery (RAB): Validity and reliability. Paper presented at: Annual Meeting of the National Cooperative Vaccine Development Group for AIDS; 1993.
8. Stein MD, Cioe P, Friedmann PD., Buprenorphine retention in primary care. J Gen Internal Med. 2005; 20: 1038-1041.
9. Fischer G, Gombas W, Eder H, et al. Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction. 1999; 94: 1337-1347.
10. Soyka M, Zingg C, Koller G, et al. Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study. Int J Neuropsychopharmacol. 2008; 11: 641-653.